Alternatives to Clinicguide

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-powered care coordination platform for faster diagnosis and treatment of critical conditions.

Digital pathology imaging technology and AI-driven precision pathology software.

Integrated drug development solutions for pharmaceutical and biotechnology companies, from preclinical to clinical trials.

Leveraging the adaptive immune system to diagnose and treat disease.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Global life sciences company providing diagnostic and biopharma laboratory services.

Develops a computational model of the human body for drug discovery and development.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

AI-powered platform for cancer diagnostics in digital pathology.

Wearable devices and AI for continuous health monitoring and early disease detection.

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered IVF clinic solutions for digitization and automation.

Healthcare analytics company making high-quality, affordable healthcare accessible through a data platform.

AI-powered spatial biology platform for precision medicine and drug development.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Developing engineered biologics to harness the immune system for disease treatment.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

AI platform for automating hospital operations and simplifying care flows.

Self-service data analytics platform for healthcare ecosystems, enabling exploration and discovery.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

AI-powered platform automating prior authorizations and medication access for healthcare providers.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

AI platform automating healthcare phone calls to improve patient access and care coordination.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Federated computing platform for secure healthcare AI development and collaboration.

Real-time patient data sharing platform for healthcare providers to improve care coordination.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Ufonia is a UK-based healthcare AI company that develops AI-powered voice agents designed to conduct routine clinical conversations with patients.

A global leader in clinical pharmacology and bioanalytical sciences.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

AI-powered medical imaging analysis for faster diagnosis and treatment in healthcare.

Developing novel immunotherapies and diagnostics for cancer.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

AI-powered EEG device for rapid seizure detection in critical care.

AI-powered eye exam for early detection of neurodegenerative diseases like Alzheimer's.

AI-powered platform that automates drug discovery through physical AI scientists and robotic experimentation.

AI-powered platform for remote orthodontic treatment monitoring.

AI-powered diagnostic system for predictive analytics in healthcare.

Digital at-home sleep lab solution for increased clinic efficiency and patient care.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.

Biotechnology company focused on developing treatments for rare metabolic diseases.

A biotechnology company developing genetic therapies for rare disorders.

AI-powered medical imaging solutions for sharper images, faster scans, and improved efficiency.

A clinical-stage biopharmaceutical company developing novel immunotherapies.